Pyoderma Gangrenosum as the First Sign of GATA2-Deficiency Associated Childhood Myelodysplastic Syndrome, Case Report and Review of Literature

Introduction: GATA 2 deficiency syndrome is an autosomal dominant genetic disease principally known as a bone marrow and immune system disorder. GATA-2 is a hematopoietic transcription factor; patients with this syndrome are prone to acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Case Presentation: Here we describe a teenage girl with GATA2 deficiency syndrome and pyoderma gangrenosum (PG) in the background of childhood myelodysplastic syndrome (cMDS) as a first presentation. Conclusions: In patients with sustained, unexplained skin lesions, especially with cytopenia, PG should be kept in mind. A bone marrow biopsy might help rule out hematologic disorders, including MDS. The MDS in children usually occurs in the context of hereditary disorders of bone marrow. Therefore, it seems wise to perform genetic testing in cMDS.

Authors

Institutions

Publication Details

Journal
Innovative Journal of Pediatrics
Published
2025-08-09
DOI
https://doi.org/10.5812/ijpediatr-162877
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pyoderma Gangrenosum as the First Sign of GATA2-Deficiency Associated Childhood Myelodysplastic Syndrome, Case Report and Review of Literature

Nima Parvaneh, Alieh Safari Sharari, Zahra Naderi, Moienadin Safavi et al.
Innovative Journal of Pediatrics
Acute Myeloid Leukemia Research
article

Pyoderma Gangrenosum as the First Sign of GATA2-Deficiency Associated Childhood Myelodysplastic Syndrome, Case Report and Review of Literature

Nima Parvaneh, Alieh Safari Sharari, Zahra Naderi, Moienadin Safavi, Fatemeh Naderi
article en

Abstract

Introduction: GATA 2 deficiency syndrome is an autosomal dominant genetic disease principally known as a bone marrow and immune system disorder. GATA-2 is a hematopoietic transcription factor; patients with this syndrome are prone to acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Case Presentation: Here we describe a teenage girl with GATA2 deficiency syndrome and pyoderma gangrenosum (PG) in the background of childhood myelodysplastic syndrome (cMDS) as a first presentation. Conclusions: In patients with sustained, unexplained skin lesions, especially with cytopenia, PG should be kept in mind. A bone marrow biopsy might help rule out hematologic disorders, including MDS. The MDS in children usually occurs in the context of hereditary disorders of bone marrow. Therefore, it seems wise to perform genetic testing in cMDS.

Innovative Journal of PediatricsVol. 35(5)
Shahrekord University of Medical Sciences (IR), Hospital Bqyhallh (IR), Children's Medical Center (IR), Tehran University of Medical Sciences (IR)
Openalex Percentile: Top 69%
Acute Myeloid Leukemia Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.